mRNA
- Stock Market
FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases
A Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with…
Read More » - Stock Market
China slams Western media for criticism of zero-COVID, as U.S. cases continue to decline
China has accused “some Western media” of bias and political manipulation in covering China’s abrupt dropping of COVID restrictions, which…
Read More » - Stock Market
WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating
The World Health Organization has called on China to release more information about its current wave of COVID infections after…
Read More » - Stock Market
New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC says
The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the…
Read More » - Stock Market
China takes first steps to punish countries that imposed testing mandates for Chinese travelers
China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for…
Read More » - Stock Market
Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic response
A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it…
Read More » - Stock Market
WHO says another omicron subvariant, which may be more resistant to antibodies, spread to 26 countries in latest week
Another omicron subvariant was determined to have spread to more countries in the week through Oct. 16 from the previous…
Read More » - Stock Market
U.S. to start vaccinating very young children this week, and panel to recommend overhauling healthcare system
The U.S. will start vaccinating children below the age of 5 starting this week, after regulatory agencies approved the shots…
Read More » - Stock Market
FDA panel reviews vaccines for children under 5, and WHO warns against pandemic complacency
A day after a panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine…
Read More » - Stock Market
Moderna’s next-generation COVID-19 shot provides ‘superior’ protection against omicron
Moderna’s MRNA, +4.10% experimental next-generation COVID-19 vaccine provides more protection against omicron than the original shot, and the company is…
Read More »